ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 13 filers reported holding ANNOVIS BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $219,000 | – | 45,598 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 12,500 | $142,000 | 0.16% |
| Wescott Financial Advisory Group, LLC | 41,607 | $472,000 | 0.13% |
| Sterling Investment Advisors, Ltd. | 26,974 | $306,000 | 0.10% |
| Knoll Capital Management, LLC | 14,210 | $161,000 | 0.09% |
| Essex LLC | 10,408 | $118,000 | 0.04% |
| FNY Investment Advisers, LLC | 3,650 | $41,000 | 0.03% |
| Modera Wealth Management, LLC | 30,913 | $351,000 | 0.02% |
| Koshinski Asset Management, Inc. | 10,000 | $113,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $268,000 | 0.01% |
| Cannell & Co. | 10,000 | $113,000 | 0.00% |